Your browser doesn't support javascript.
loading
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh, Ryan; Dos Santos, Claudio; Hanson, Liam; Ng, Christabella; Major, Giles; Smyth, Alan R; Rivett, Damian; van der Gast, Christopher.
Affiliation
  • Marsh R; Department of Applied Sciences, Northumbria University , Newcastle, United Kingdom.
  • Dos Santos C; Department of Natural Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
  • Hanson L; Department of Natural Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
  • Ng C; Department of Life Sciences, Manchester Metropolitan University , Manchester, United Kingdom.
  • Major G; School of Medicine, University of Nottingham , Nottingham, United Kingdom.
  • Smyth AR; NIHR Nottingham Biomedical Research Centre , Nottingham, United Kingdom.
  • Rivett D; School of Medicine, University of Nottingham , Nottingham, United Kingdom.
  • van der Gast C; Nestlé Institute of Health Sciences, Société des Produits Nestlé , Lausanne, Switzerland.
Microbiol Spectr ; : e0117523, 2023 Aug 21.
Article in En | MEDLINE | ID: mdl-37607068
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Microbiol Spectr Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Microbiol Spectr Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos